Table 2.

Uni- and Multivariate Fine&GrayCompetingRiskRegressionAnalyses for Relapse and NRM

		Relapse						NRM
		Univariate competing risk regression			Multivariate competing risk regression			Univariate competing risk regression			Multivariate competing risk regression
		SHR (95% CI)	p		SHR (95% CI)	p		SHR (95% CI)	p		SHR (95% CI)	p
Age		0.98 (0.97-0.99)		0.001	1.00 (0.99-1.01)		0.19	1.00 (0.99-1.02)		0.460
Sex Matching	Sex matched	1(Ref.)			1(Ref.)			1(Ref.)			1(Ref.)
	Male to female	0.64 (0.49-0.83)		0.001	0.67 (0.48-0.93)		0.019	1.14 (0.70-1.84)		0.598	1.30 (0.80-2.11)		0.29
	Female to male	0.75 (0.58-0.96)		0.023	0.90 (0.66-1.22)		0.514	2.48 (1.68-3.67)		0.000	2.59 (1.70-3.95)		0.000
cGvHD	No	1(Ref.)			1(Ref.)			1(Ref.)			1(Ref.)
	Limited	0.66 (0.51-0.86)		0.002	0.64 (0.47-0.89)		0.007	0.92 (0.47-1.81)		0.812	0.89 (0.45-1.76)		0.742
	Extensive	0.30 (0.24-0.39)		0.000	0.31 (0.23-0.41)		0.000	2.04 (1.28-3.27)		0.003	1.70 (1.04-2.78)		0.034
CMV Risk	Low	1(Ref.)			1(Ref.)			1(Ref.)
	intermediate	.83 (0.40-1.74)		0.63	0.85 (0.43-1.69)		0.639	0.92 (0.28-3.01)		0.886
	High	0.59 (0.39-0.89)		0.012	0.61 (0.41-0.89)		0.012	0.66 (.35-1.26)		0.215
Primary Disease	ALL	1(Ref.)			1(Ref.)			1 (Ref.)
	AML	0.46 (0.38-0.57)		0.000	0.45 (0.34-0.59)		0.000	1.12 (0.79-1.6)		0.520
CMV	No	1(Ref.)						1 (Ref.)			1(Ref.)
	Yes	1.00 (0.81-1.25)		0.94				1.54 (1.09-2.20)		0.015	1.62 (1.11-2.38)		0.013
aGvHD	No & I	1(Ref.)			1(Ref.)			1 (Ref.)			1(Ref.)
	II & III	0.87 (0.71-1.06)		0.166	0.88 (0.69-1.14)		0.350	1.74 (1.23-2.48)		0.002	1.29 (.88-1.90)		0.19
Donor Type	Full Matched Sibling	1(Ref.)						1 (Ref.)
	Others	0.84 (0.54-1.31)		0.455				0.52 (0.19-1.42)		0.203

NRM, Non-Relapse Mortality; SHR, Sub-Distribution Hazard Ratio